Literature DB >> 22013093

The physical, psychological and social impact of psoriasis.

S R Rapp1, M L Exum, D M Reboussin, S R Feldman, A Fleischer, A Clark.   

Abstract

Psoriasis is a chronic, disabling skin disease affecting up to 2 percent of the population. Little is known about how physical, psychological and social features of the illness interact to create a negative impact. In this article, a biopsychosocial model of the impact of psoriasis is described, and results from a survey of 317 psoriasis patients are presented. The types of functional disability, psychological distress and disease-related stressors are described for highly strained patients (i.e. those with disease-related suicidal ideation) and compared with less strained patients (i.e. those without suicidal ideation). As predicted by the model, significantly more disability, psychological distress and disease-related stressors are found among highly strained patients. Logistical regression analysis revealed that strain is more strongly associated with disability, distress and disease-related stress level than with disease severity. Implications for research and clinical interventions are discussed.

Entities:  

Year:  1997        PMID: 22013093     DOI: 10.1177/135910539700200409

Source DB:  PubMed          Journal:  J Health Psychol        ISSN: 1359-1053


  10 in total

1.  Exploring genetic targets of psoriasis using genome wide association studies (GWAS) for drug repurposing.

Authors:  Harshit Nanda; Nirmaladevi Ponnusamy; Rajasree Odumpatta; Jeyaraman Jeyakanthan; Arumugam Mohanapriya
Journal:  3 Biotech       Date:  2020-01-10       Impact factor: 2.406

2.  Emotion Regulation in Patients with Psoriasis: Correlates of Disability, Clinical Dimensions, and Psychopathology Symptoms.

Authors:  Vera Almeida; Sofia Taveira; Maribel Teixeira; Isabel Almeida; José Rocha; Ana Teixeira
Journal:  Int J Behav Med       Date:  2017-08

Review 3.  Monoclonal antibodies inhibiting IL-12, -23, and -17 for the treatment of psoriasis.

Authors:  Caleb Jeon; Sahil Sekhon; Di Yan; Ladan Afifi; Mio Nakamura; Tina Bhutani
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

Review 4.  Stress and atopic dermatitis.

Authors:  Jenna Arndt; Nananamibia Smith; Francisco Tausk
Journal:  Curr Allergy Asthma Rep       Date:  2008-07       Impact factor: 4.806

5.  Prevalence of psoriasis among adults in the U.S.: 2003-2006 and 2009-2010 National Health and Nutrition Examination Surveys.

Authors:  Charles G Helmick; Hyewon Lee-Han; Shawn C Hirsch; Tiffany L Baird; Christopher L Bartlett
Journal:  Am J Prev Med       Date:  2014-04-18       Impact factor: 5.043

6.  Calcipotriol and betamethasone dipropionate in the treatment of mild-to-moderate psoriasis: a cost-effectiveness analysis of the ointment versus gel formulation.

Authors:  Giorgio L Colombo; Sergio Di Matteo; Giacomo Bruno; Giampiero Girolomoni; Gino Antonio Vena
Journal:  Clinicoecon Outcomes Res       Date:  2012-09-13

Review 7.  Guselkumab for the Treatment of Psoriasis: A Review of Phase III Trials.

Authors:  Mio Nakamura; Katherine Lee; Caleb Jeon; Sahil Sekhon; Ladan Afifi; Di Yan; Kristina Lee; Tina Bhutani
Journal:  Dermatol Ther (Heidelb)       Date:  2017-06-21

8.  Cognition/Psychological Burden and Resilience in Cutaneous T-Cell Lymphoma and Psoriasis Patients: Real-Life Data and Implications for the Treatment.

Authors:  Giovanni Damiani; Joselin D Tacastacas; Timothy Wuerz; Lindsay Miller; Philip Fastenau; Christopher Bailey; Mansi Sethi Chawa; Amanda Argenas; Marco Fiore; Kevin D Cooper; Alan J Lerner
Journal:  Biomed Res Int       Date:  2022-07-21       Impact factor: 3.246

9.  Communicating Cardiovascular Disease Risk to People with Psoriasis: What Techniques do Practitioners Use?

Authors:  Chris Keyworth; Pauline A Nelson; Carolyn A Chew-Graham; Karen Kane; Christina J Pearce; Christopher E M Griffiths; Anna Chisholm; Lis Cordingley
Journal:  Int J Behav Med       Date:  2016-04

10.  Adherence to Topical Therapies for the Treatment of Psoriasis: Surveys of Physicians and Patients.

Authors:  Jee Woong Choi; Bo Ri Kim; Sang Woong Youn
Journal:  Ann Dermatol       Date:  2017-08-25       Impact factor: 1.444

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.